Oevrum Margareth
Known title: DirectorCIK: 0001678435
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Analyst Coverage Updates for TechnipFMC (FTI). Barclays keeps an overweight stance on TechnipFMC but lowered its price target to $86. UBS has initiated coverage with a buy rating and a target of $89. These updates reflect a mixed but generally positive view from analysts, amid a sector backdrop highlighted by Halliburton's Q3 earnings preview.
Transaction History
| FMC | ▼ Sell | Tax Withholding | 680 | $11K | 4/28/2026 | View on chart |
| FMC | ▲ Buy | Grant | 84 | $0 | 4/16/2026 | View on chart |
| FTI | ▲ Buy | Grant | 3,259 | $0 | 2/16/2026 | View on chart |
| FMC | ▲ Buy | Grant | 103 | $0 | 1/15/2026 | View on chart |
| FMC | ▲ Buy | Grant | 302 | $0 | 10/16/2025 | View on chart |
| FMC | ▲ Buy | Grant | 240 | $0 | 7/17/2025 | View on chart |
| FMC | ▲ Buy | Grant | 3,355 | $0 | 4/29/2025 | View on chart |
| FMC | ▲ Buy | Grant | 202 | $0 | 4/17/2025 | View on chart |
| FTI | ▲ Buy | Grant | 6,350 | $0 | 2/24/2025 | View on chart |
| FMC | ▲ Buy | Grant | 173 | $0 | 1/16/2025 | View on chart |
| FMC | ▲ Buy | Grant | 127 | $0 | 10/17/2024 | View on chart |
| FMC | ▲ Buy | Grant | 144 | $0 | 7/18/2024 | View on chart |
| FMC | ▲ Buy | Grant | 2,373 | $0 | 4/30/2024 | View on chart |
| FMC | ▲ Buy | Grant | 118 | $0 | 4/18/2024 | View on chart |
| FTI | ▲ Buy | Grant | 9,381 | $0 | 2/20/2024 | View on chart |
| FMC | ▲ Buy | Grant | 118 | $0 | 1/18/2024 | View on chart |
| FMC | ▲ Buy | Grant | 111 | $0 | 10/19/2023 | View on chart |
| FMC | ▲ Buy | Grant | 71 | $0 | 7/20/2023 | View on chart |
| FMC | ▲ Buy | Grant | 1,150 | $0 | 4/27/2023 | View on chart |
| FMC | ▲ Buy | Grant | 55 | $0 | 4/20/2023 | View on chart |
| FTI | ▲ Buy | Grant | 12,491 | $0 | 2/21/2023 | View on chart |
| FMC | ▲ Buy | Grant | 59 | $0 | 1/19/2023 | View on chart |
| FMC | ▲ Buy | Grant | 64 | $0 | 10/20/2022 | View on chart |
| FMC | ▲ Buy | Grant | 63 | $0 | 7/21/2022 | View on chart |
| FMC | ▲ Buy | Grant | 45 | $0 | 4/29/2022 | View on chart |
| FMC | ▲ Buy | Grant | 1,412 | $0 | 4/28/2022 | View on chart |
| FTI | ▲ Buy | Grant | 22,208 | $0 | 3/8/2022 | View on chart |
| FMC | ▲ Buy | Grant | 53 | $0 | 1/20/2022 | View on chart |
| FMC | ▲ Buy | Grant | 57 | $0 | 10/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
FMC completes minority stake with Tessenderlo, sets Q3 earnings date
FMC Corporation and Tessenderlo Group have completed a minority equity investment, adding a new strategic partner to the business. The company also announced the date for its third‑quarter 2026 earnings release and the accompanying webcast. Recent commentary noted that the stock has fallen sharply, making it appear inexpensive relative to sales, a point that may be of interest given its current price near a long‑standing support level.
FMC completes minority stake with Tessenderlo, sets Q3 earnings date. FMC Corporation and Tessenderlo Group have completed a minority equity investment, adding a new strategic partner to the business. The company also announced the date for its third‑quarter 2026 earnings release and the accompanying webcast. Recent commentary noted that the stock has fallen sharply, making it appear inexpensive relative to sales, a point that may be of interest given its current price near a long‑standing support level.